USPTO-FDA study reinforces the need to protect pharmaceutical intellectual property rights for the future of new drug development.
The IRA Has Undermined Medicare Part D
The Inflation Reduction Act creates instability in the Medicare Part D Program.
Not-So-Happy Birthday to the Inflation Reduction Act
The Inflation Reduction Act will ultimately raise drug costs and reduce future cures.
Court Further Delays Net Neutrality Implementation
On August 1, 2024, the U.S. Court of Appeals for the Sixth Circuit extended the stay on the FCC’s latest net neutrality order.
Fifth Circuit Determines the USF Fee Is a Tax
The Fifth Circuit Court rocked the telecommunications world when it released its ruling on funding the USF.
House Defense Bills Break with Pentagon Guidance
Putting the customer at the core of your product development ensures relevance and resonance.
The FTC Wrongly Blames PBMs for High Drug Prices
Putting the customer at the core of your product development ensures relevance and resonance.
New Study Shows PBMs Lower Drug Prices
A new report challenges assertions made during the committee’s recent hearing on the role of pharmacy benefit managers.
Antitrust Regulators Play Monopoly: Rolling the Dice on Artificial Intelligence
Antitrust investigations of AI companies will likely stifle innovation and jeopardize US global competitiveness.
Broadband Rollout Requires Municipal Permitting Reform
Municipal leaders can expand broadband connectivity by lifting restraints on cell towers, fiber, and utility pole attachments.






